Esperion Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ESPR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

715,326

Value ($000)

2,647

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,647	0.0%	715,326	12/31/2025
2025 Q3	11/10/2025	1,554	0.0%	586,424	9/30/2025
2025 Q2	8/12/2025	608	0.0%	617,139	6/30/2025
2025 Q1	9/15/2025	798	0.0%	554,216	3/31/2025
2024 Q4	2/6/2025	1,219	0.0%	554,216	12/31/2024
2024 Q3	11/12/2024	916	0.0%	554,914	9/30/2024
2024 Q2	8/12/2024	1,232	0.0%	554,914	6/30/2024
2024 Q1	5/9/2024	155	0.0%	57,991	3/31/2024
2023 Q4	2/6/2024	173	0.0%	57,991	12/31/2023
2023 Q3	11/8/2023	57	0.0%	57,991	9/30/2023
2023 Q1	5/12/2023	318	0.0%	199,811	3/31/2023
2022 Q4	2/13/2023	1,227	0.0%	196,952	12/31/2022
2022 Q3	11/14/2022	1,138	0.0%	169,826	9/30/2022
2022 Q2	8/15/2022	1,030	0.0%	161,815	6/30/2022
2022 Q1	5/13/2022	707	0.0%	152,209	3/31/2022
2021 Q4	2/11/2022	404	0.0%	80,660	12/31/2021
2021 Q3	11/16/2021	821	0.0%	68,083	9/30/2021
2021 Q2	8/16/2021	4,030	0.0%	190,497	6/30/2021
2021 Q1	5/17/2021	5,223	0.0%	186,182	3/31/2021
2020 Q4	2/16/2021	4,714	0.0%	181,288	12/31/2020
2020 Q3	11/13/2020	6,618	0.0%	178,025	9/30/2020
2020 Q2	8/20/2020	8,682	0.0%	169,202	6/30/2020
2020 Q1	5/15/2020	5,794	0.0%	183,731	3/31/2020
2019 Q4	2/7/2020	13,235	0.0%	221,952	12/31/2019